Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, et al
The short half-life of native GLP- 1-based therapy in the circulation (approximately two minutes after intravenous administration and one to five hours after subcutaneous administration) posed a problem during its early development [9]
Talk to your healthcare provider if you have any concerns about possible drug interactions or side effects
Specifically, BV2 and HT22 cells were incubated in 24well plates (1 10 5 cells/well) for 24 h
For a 5 mg vial, 1 mL of water gives 5 mg/mL
Preclinical investigations indicate that the peptide may attenuate behavioral and functional disturbances in rodent models of neurodegeneration induced by neurotoxic agents such as MPTP and reserpine